Stocks in play: Satellos Bioscience Inc.
Announced a presentation of data at the 29th Annual Congress of the World Muscle Society taking place ...
Stocks in play: Satellos
For the three months ended June 30, 2024, reported a net loss of $6.0 million ($0.05 loss per share), ...
Satellos Bioscience: Q2 Earnings Snapshot
Satellos Bioscience: Q2 Earnings Snapshot
Stocks in play: Satellos Bioscience Inc.
Today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical ...
Stocks in play: Satellos Bioscience Inc.
Announced today the formation of a Clinical Advisory Board comprised of distinguished clinical research ...
Satellos Bioscience Inc. Opens the Market
/CNW/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani...
Stocks in play: Satellos Bioscience Inc.
Announced today its financial results and operational highlights for the year ended December 31, 2023. ...